Ni Fang's Form 4 filing
Black Diamond Therapeutics, Inc. (BDTX) · filed Dec 23, 2022
- Accession no.
- 0001415889-22-012966
- Filed
- Dec 23, 2022
- Trade date
- Dec 21-22, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $72.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ni FangCIK 0001895910 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $1.29 | +$25,800 | 89,026 | Direct | |
| Dec 22, 2022 | Common Stock | PPurchaseAcquired | +36,363 | $1.28 | +$46,544.64 | 125,389 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.